With increasing frequency over the past few years, optometrists across the country have gotten referrals from internists requesting baseline diabetic retinopathy (DR) screenings for patients about to start therapy with one of the glucagon-like peptide-1 (GLP-1)/glucose-dependent insulinotropic polypeptide (GIP) receptor agonists such as semaglutide (Ozempic, Novo Nordisk), tirzepatide (Mounjaro, Eli Lilly) and dulaglutide (Trulicity, Eli Lilly
W.SchnitkerJ
Improved Adherence The ease of oral administration can lead to better treatment adherence, improving overall patient outcomes
Growth hormone affects practically every bodily tissue and organ.6 Its chiefly responsible for facilitating physical growth and metabolism, the process of converting food into usable energy.7 The metabolic effects of growth hormone are due to its stimulating effect on the production of insulin-like growth factor-1 (IGF-1), which is important for regulating body composition
Here are the main ones: For Weight Loss: Wegovy (semaglutide) Zepbound (tirzepatide) Saxenda (liraglutide) For Diabetes (sometimes used for weight loss): Ozempic (semaglutide) Mounjaro (tirzepatide) Trulicity (dulaglutide) Victoza (liraglutide) Rybelsus (oral semaglutide) Most GLP-1 medications come as shots you give yourself once a week
TEM revealed mitochondrial cristae disruption, swelling, rupture, and intracellular lipid droplet accumulation, suggesting impaired lipid metabolism and energy production in TECs
